MBRX
Moleculin Biotech Inc
NASDAQ: MBRX · HEALTHCARE · BIOTECHNOLOGY
$2.48
-0.40% today
Updated 2026-05-06
Market cap
$13.39M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-28.42
Dividend yield
—
52W range
$2 – $29
Volume
0.1M
Moleculin Biotech Inc (MBRX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-423509.00 | $-3.76M | $-7.32M | $-12.20M | $-17.20M | $-17.77M | $-18.95M | $-27.64M | $-24.10M | $-23.86M | $-22.73M |
| Capital expenditures | $21000.00 | $21470.00 | $28000.00 | $417000.00 | $52000.00 | $376000.00 | $19000.00 | $67000.00 | $124000.00 | $13000.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $411474.00 | $707000.00 | $1.14M | $1.54M | $1.68M | $2.37M | $2.27M | $1.98M | $1.73M | $1.66M |
| Free cash flow | $-444509.00 | $-3.79M | $-7.35M | $-12.62M | $-17.25M | $-18.15M | $-18.97M | $-27.71M | $-24.23M | $-23.88M | $-22.73M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | $0.00 | $0.00 | — | — | — | — | — | — | — | $104000.00 |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | $4.98M | $2.71M | $-580000.00 | $3.60M | $4.40M | — | — | — | — | — |